Global Gastric Cancer Market Research and Forecast 2017-2022

INDORE, India - July 17, 2018 - PRLog -- The Gastric cancer market is expected to grow at a modest CAGR of 5.8% during 2017-2022. Growing elderly population, technological advancement and rising incidence and prevalence rate of gastric cancer are boosting the stomach cancer market across the globe. Gastric cancer leads to uncontrolled progress of malignant cells that originate in stomach tissue. The main cause for the developing stomach cancer is still not known exactly, but bacterium Helicobacter Pylori is one of the key cause and also Smoking & ulcer are some factors leading to stomach cancer. Other factor included such as age, diet, and stomach disease can affect the risk of developing stomach cancer. Approx. 800,000 cancer related death are causes by gastric cancer every year, as per World Health Organization.

According to National Institute of Cancer, United States the stomach cancer is common in both men and women. Age, diet and stomach disease, including infection with Helicobacter pylori can affect the risk of developing stomach cancer. The number of new cases of stomach cancer was 7.3 per 100,000 men and women per year based on 2010-2014 cases.

The Gastric cancer testing market can be segmented majorly into three parts on the basis of testing type, drug class, treatment type and end users. Testing type, the industry further segmented into chest x-ray, computed tomography (CT or CAT) scan, helicobacter pylori, imaging tests, laparoscopy, magnetic resonance imaging (MRI) scan, positron emission tomography (PET) scan and upper gastrointestinal (GI) series. And on the basic of drug class market can be segmented into Docetaxel, Doxorubicin Hydrochloride, Fluorouracil, Imatinib, Mitomycin C, Sunitinib And Trastuzumab. And lastly treatment type can be segmented into adjuvant chemotherapy, chemo therapy, radiation therapy, surgery and targeted drugs therapy. The stomach cancer market is rising rapidly as increasing incidence of adenocarcinoma, gastrointestinal stromal tumors and lymphoma across the globe. Most significant drivers are for the stomach cancer market include, increasing number of cancer treatment centers, treatment advancements, combination therapies, large number of regulatory approvals for metastatic gastric cancer and low dose radiation technology based devices.

Some Brief Table of Contents of Report

REPORT SUMMARY

1.1. RESEARCH METHODS AND TOOLS

1.2. MARKET BREAKDOWN

MARKET OVERVIEW AND INSIGHTS

2.1. DEFINITION

2.2. ANALYST INSIGHTS & CURRENT MARKET TRENDS

MARKET DETERMINANT

3.1. MOTIVATORS

3.2. RESTRAINT

3.3. OPPORTUNITY

MARKET SEGMENTATION

4.1. GASTRIC CANCER TESTING MARKET RESEARCH AND ANALYSIS BY TESTING TYPE

4.2. GASTRIC CANCER TESTING MARKET RESEARCH AND ANALYSIS BY DRUG CLASS

4.3. GASTRIC CANCER TESTING MARKET RESEARCH AND ANALYSIS, BY TREATMENT TYPE

4.4. GASTRIC CANCER TESTING MARKET RESEARCH AND ANALYSIS, BY END USER

COMPETITIVE LANDSCAPE

5.1. KEY STRATEGIES

5.2. KEY COMPANY ANALYSIS

Continued TOC....

Browse full report at: https://www.omrglobal.com/industry-reports/gastric-cancer...

For Related Report: https://www.omrglobal.com/reports-category/pharmaceuticals/